FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
批准号:
6476789
负责人:
MARTIN M. MATZUK
金额:
$25.88万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-17 至 2004-05-31
关键词:
biological signal transduction follistatin gene expression gene targeting genetically modified animals hormone binding protein hormone receptor immunocytochemistry inhibin laboratory mouse lethal genes mammalian embryology northern blottings postnatal growth disorder protein structure function radionuclides reproductive development southern blotting tissue /cell culture transforming growth factors
中文摘要
在哺乳动物中,大约有10万个基因控制着
生物体的发育。为了使开发正常进行,有
一定是成千上万个这样的基因协同作用
存在的任何给定细胞中的产品。从受精开始,
这些基因产物在胚胎期间的精确表达是必需的,
胎儿、出生后和成人的发育。偶一的异常合成
这些基因产物中的一种可能是灾难性的-出生缺陷,癌症,
当这种发育时,不孕不育,甚至死亡都是可能的
程序被更改。为了充分了解人类的这些过程,它
是有必要的生理模型,以密切模拟
在人类创造过程中发生的发育事件。
为此,我们选择小鼠作为我们的
学习。现在有可能修改小鼠基因组以产生
具有精确基因突变的小鼠品系。使用这项技术,
我们实验室已经创造了几个有出生缺陷的模型。为
例如,激活素BetaA和卵泡抑素基因突变的小鼠
出生时死亡并患有腭裂,这是人类常见的先天缺陷
病因不明。此外,小鼠激活素受体基因突变
II型基因有骨骼和面部的异常,类似于
人类皮埃尔-罗宾综合征;患有这种综合征的人类新生儿
下颌骨缺陷,导致呼吸窘迫,必须
立即手术矫正。在这项拨款建议中,我们将
利用这些先前创建的鼠标模型以及其他
对此进行研究的模型(即缺乏激活素Betac和BetaE的小鼠
复杂的信号转导系统。具体目标是:1)界定
肝脏特异性转化生长因子-β超家族成员激活素的功能
Betac和BetaE;2)执行激活素BETAB“敲门”以尝试
抢救激活素βA基因敲除小鼠;3)研究出生后
卵泡抑素和激活素βA在诱导基因敲除中的作用
系统。利用这些小鼠作为活体哺乳动物模型的未来研究
系统将使我们能够更充分地了解相互关联的角色
这些蛋白质在哺乳动物发育和生理学中的作用。
英文摘要
In mammals, there are approximately 100,000 genes which govern the
development of an organism. For development to proceed normally, there
must be coordinate interaction of tens of thousands of these gene
products in any given cell of the being. Beginning with fertilization,
precise expression of these gene products is required during embryonic,
fetal, postnatal, and adult development. Aberrant synthesis of even one
of these gene products can be disastrous - birth defects, cancer,
infertility, and even death are all possible when this developmental
program is altered. To fully understand these processes in humans, it
is necessary to have physiological models that closely mimic
developmental events which occur during the creation of a human being.
Toward this end, we have chosen the mouse as the mammalian model for our
studies. It is now possible to modify the mouse genome to generate
strains of mice with precise genetic mutations. Using this technology,
our laboratory has created several models which have birth defects. For
example, mice with mutations in the activin betaA and follistatin genes
die at birth and have cleft palate, a common birth defect in humans of
unknown etiology. In addition, mice a mutations in the activin receptor
type II gene have skeletal and facial abnormalities which mimic the
human Pierre-Robin syndrome; human newborns with this syndrome have
defects in the mandible, leading to respiratory distress which must be
surgically corrected immediately. In this grant proposal, we will
utilize these previously created mouse models as well as additional
models (i.e., mice lacking activins betaC an betaE) to study this
complex signal transduction system. The Specific Aims are: 1) Define the
functions of the liver-specific TGF-beta-superfamily members, activins
betaC and betaE; 2) Perform an activin betaB "knockin" to attempt a
rescue of activin betaA knockout mice; and 3) Study the postnatal
functions of follistatin and activin betaA using inducible knockout
systems. Future studies using these mice as in vivo mammalian model
systems will enable us to more fully understand the interrelated roles
of these proteins in mammalian development and physiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10682061
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Kinases as Therapeutic Targets for Endometriosis
-
批准号:10674987
-
项目类别:
-
资助金额:$68.77万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10764639
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10419647
-
项目类别:
-
资助金额:$10.15万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10598585
-
项目类别:
-
资助金额:$70.24万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Kinases as Therapeutic Targets for Endometriosis
-
批准号:10532966
-
项目类别:
-
资助金额:$68.77万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Targeting testis-specific ubiquitin-proteasome pathways for male contraception
-
批准号:10018522
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2019
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional genomics and DEC-Tec to identify germ cell-specific contraceptives
-
批准号:10164823
-
项目类别:
-
资助金额:$121.0万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Administrative Core
-
批准号:9278437
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Administrative Core
-
批准号:10164824
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Targeting sperm-specific proteins during meiosis and sperm morphogenesis
-
批准号:10164826
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Targeting sperm-specific proteins during meiosis and sperm morphogenesis
-
批准号:9278439
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional analysis of novel testis-expressed secreted and transmembrane proteins
-
批准号:10597610
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2016
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional analysis of novel testis-expressed secreted and transmembrane proteins
-
批准号:10378949
-
项目类别:
-
资助金额:$50.92万
-
财政年份:2016
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional analysis of novel testis-expressed secreted and transmembrane proteins
-
批准号:9324300
-
项目类别:
-
资助金额:$39.29万
-
财政年份:2016
-
负责人:MARTIN M. MATZUK
-
依托单位:
Mouse Models to Study Gonadal Tumor Development
-
批准号:7914962
-
项目类别:
-
资助金额:$5.29万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
Defining the Mammalian Intercellular Bridge Interactome
-
批准号:7582169
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
ANALYSIS OF REPRODUCTIVE FUNCTION USING TRANSGENIC MICE
-
批准号:7935154
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
identification of small molecule contraceptives that target the male germline
-
批准号:8064005
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
identification of small molecule contraceptives that target the male germline
-
批准号:8223290
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Follistatin调控脊椎动物左右不对称发育的机制研究
-
批准号:31970757
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2019
-
负责人:徐鹏飞
-
依托单位:
Activin/follistatin信号系统对中华鲟卵巢发育的调控及作用机制
-
批准号:31802282
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2018
-
负责人:岳华梅
-
依托单位:
祛瘀生肌法通过Follistatin/Activin信号通路改善糖尿病溃疡炎症微环境的相关机制研究
-
批准号:81673866
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2016
-
负责人:李福伦
-
依托单位:
Follistatin与连续性牙齿(Successional Teeth)发育的遗传学控制
-
批准号:81570941
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:张遵义
-
依托单位:
调控Follistatin基因促进全身骨骼肌细胞增生及改善运动功能的研究
-
批准号:81100938
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:郑卉
-
依托单位:
Activin和Follistatin基因在不同倍性鲫鲤的表达及育性相关性研究
-
批准号:31001105
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:陶敏
-
依托单位:
牙鲆Follistatin 和Myostatin基因的克隆及其表达和功能分析
-
批准号:30871929
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:张培军
-
依托单位: